Xalkori 250 mg, Hartkapseln

7680621310035 CH-62131 Kapseln

Associated product:

XALKORI caps 250 mg 60 pce
Xalkori 250 mg, Hartkapseln
Xalkori 250 mg, Hartkapseln
1 / 2
google

Article details

Package size
60
Selling units
60
Measure
Kapsel(n)
Galenic form
Kapseln
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
23/07/2025
Patient information leaflet
Français
23/07/2025
Patient information leaflet
Italien
23/07/2025
Summary of Product Characteristics
Allemand
23/07/2025
Summary of Product Characteristics
Français
23/07/2025
Summary of Product Characteristics
Italien
23/07/2025

Detailed composition

Substance Quantity Type Category
(N/A)
250.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
1.05 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance HNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FTODK

Reimbursement information

Public price
CHF 5068.65
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/06/2013

Authorization holder

Pfizer AG

8052 Zürich

Authorization information

Swissmedic authorization number
62131
Drug name
Xalkori, Hartkapseln
Galenic form
KAHA
ATC Code
L01ED01
Authorization status
Z
Dispensing category
A
First authorization
05/03/2012
Authorization expiration date
31/12/9999
IT Number
07.16.1.
Domain
Human medicine
Field of application
Onkologikum

Package details

Description (FR)
XALKORI caps 250 mg 60 pce
Description (DE)
XALKORI Kaps 250 mg 60 Stk
Market launch
05/03/2012
Narcotic (BTM)
No

Other package sizes (1)

XALKORI caps 200 mg 60 pce
60 KAP
GTIN: 7680621310011
View